Free Judgment - District Court of Delaware - Delaware

Case 1:07-cv-00138-JJF Document 48 Filed 11/29/2007 Page1 0f2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
PFIZER INC., PFIZER :
PHARMACEUTICALS, LLC, :
PFIZER LIMITED, C.P. :
PHARMACEUTICALS INTERNATIONAL :
C.V., PFIZER IRELAND :
PHARMACEUTICALS, WARNER- :
LAMBERT COMPANY, WARNER :
LAMBERT COMPANY LLC, and :
WARNER—LAMBERT EXPORT, LTD., :
Plaintiffs, z
v. : Civil Action No. 07-138-JJF
RANBAXY LABORATORIES LIMITED Q
and RANBAXY INC., :
Defendants. :
JUDGMENT ORDER
WHEREAS, Defendants, Ranbaxy Laboratories Limited and
Ranbaxy Inc., do not contest infringement of United States Patent
No. 4,681,893 (the “‘893 patent), and for the reasons set forth
in the Opinion dated November 29, 2007, the Court has concluded
that Defendants are precluded from challenging the validity and
enforceability of the ‘893 patent and its patent term extension
in this action;
NOW THEREFORE, IT IS HEREBY ORDERED AND ADJUDGED this 29th
day of November 2007, that judgment shall be entered in favor of
Plaintiffs, Pfizer Inc., Pfizer Pharmaceuticals, LLC, Pfizer
Limited, C.P. Pharmaceuticals International C.V., Pfizer Ireland
Pharmaceuticals, Warner—Lambert Company, Warner Lambert Company

Case 1:07-cv-00138-JJF Document 48 Filed 11/29/2007 Page 2 012
LLC, and Warner—Lambert Expert, Ltd. en Plaintiffs’ claim that
Ranbaxy has infringed the ‘893 patent under 35 U.S.C. §
27i(e)(2).
i§%EED§S'I'AT1% DISTRICT JUI>%
Dated: November 29, 2007
W /»/% Lwisf
(By) Deputy Clerk